/People

Stacie Weninger

Investor

Venture Partner at F-Prime Capital

Massachusetts

Writes $100K – $10M checks · typically $5M

Find your path to Stacie

483 people in our graph can introduce you to Stacie.

Sign up to see every warm intro you have to Stacie

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Stacie. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Likely email· guessed from name + firm domain, not firm-published

Experience

  1. F-Prime Biomedical Research InitiativeExecutive Directorcurrent2009 — present
  2. FidelityScience Program Director2005 — 2009
  3. Harvard UniversitySenior Analyst and Project Manager, Task Force on Women in Science2005
  4. Cell PressSenior Scientist, Neuron2001 — 2005

Deals · 1

Neumora TherapeuticsBoard seat

via F-Prime Capital · filed Jan 2023 · $474.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at F-Prime Capital

Frequently asked questions

Who is Stacie Weninger?
Venture Partner at F-Prime Capital Partners
Where does Stacie Weninger work?
Stacie Weninger is Venture Partner at F-Prime Capital.
What check size does Stacie Weninger write?
Stacie Weninger typically writes checks of $100K – $10M.
What boards does Stacie Weninger sit on?
Stacie Weninger holds tracked board seats at Neumora Therapeutics.
What companies has Stacie Weninger invested in?
Investments tracked here include Atalanta, Denali Therapeutics, Engrail Therapeutics, Neumora Therapeutics, Tenvie.
Where did Stacie Weninger go to school?
Stacie Weninger studied at Harvard University (Doctor of Philosophy (Ph.D.), Neuroscience).

Same school

Shared employers